Core Points - Tailin Bio announced that its wholly-owned subsidiary, Tailin Medical Devices, has recently obtained a patent for an "automated equipment for microbial limit testing" [2] Company Summary - Tailin Bio's subsidiary, Tailin Medical Devices, has secured a new patent, indicating ongoing innovation and development in the field of medical devices [2]

Core Viewpoint - The company has recently obtained a utility model patent for an automated microbial limit testing device, which will enhance its intellectual property protection and core competitiveness in the long term [1] Group 1: Patent Acquisition - The patent is titled "An Automated Device for Microbial Limit Testing" with application number 2024218453749 [1] - The patent was officially announced on September 5, 2025 [1] Group 2: Impact on Business - The acquisition of this patent is not expected to have a significant impact on the company's short-term production and operations [1] - The patent will contribute to the company's ongoing innovation mechanism and strengthen its independent intellectual property advantages [1]